Analytical audits play a critical role in ensuring pharmaceutical products meet regulatory standards for safety, quality, and consistency. Being prepared in both your analytical methods and documentation is essential, whether you are facing an internal review, a sponsor audit, or a formal regulatory inspection.
Key Takeaways
-
- Analytical audits assess data integrity, equipment calibration, method validation / method transfer and GMP compliance.
-
- Proactive preparation reduces audit findings and leads to better regulatory outcomes.
-
- Partnering with an experienced CDMO can streamline readiness across analytical operations.
What Is an Analytical Audit in Pharma?
An analytical audit is a structured review of the processes, methods, and records associated with laboratory testing of pharmaceutical products. These audits can be conducted by regulatory authorities (e.g. TGA, FDA), third-party sponsors, or internal QA teams. Their goal is to verify that all analytical procedures and documentation comply with Good Manufacturing Practice (GMP) and regulatory standards.
Key focus areas typically include:
-
- Method validation and transfer
-
- Instrument calibration and maintenance
-
- Raw data integrity and traceability
-
- Analyst training and SOP compliance
-
- Laboratory investigations
-
- Laboratory controls and risk management practices
Inadequate audit preparation can result in audit observations, delays, or regulatory action — making it critical for teams to approach audits with a proactive mindset.
Types of Analytical Audits and Who Conducts Them
Different types of audits can occur during the drug development lifecycle:
-
- Internal audits – Led by in-house QA to identify and correct gaps before external audits/inspections.
-
- Sponsor audits / inspections – Conducted by the pharma / sponsor company outsourcing analytical work to a CDMO.
-
- Regulatory inspections – Performed by regulatory agencies like the TGA or FDA as part of GMP licensing or marketing authorisation.
-
- For-cause audits – Triggered by specific concerns such as data integrity/discrepancies or out of specification (OOS) results.
Pharma companies must ensure their analytical service providers are audit-ready at all times — especially when handling release testing, stability studies, or critical method development and validation.
How to Prepare for an Analytical Audit
1. Review Analytical Method Validation and Transfer Records
Ensure all methods used in your lab are fully validated for their intended use. If methods were transferred from another site or sponsor, proper transfer documentation should be available and complete.
Include:
-
- Method transfer protocols and acceptance criteria
-
- Method validation reports (specificity, linearity, accuracy, precision, robustness)
-
- Evidence of any updates, re-validations, or deviations
2. Ensure Equipment Calibration and Qualification Is Up to Date
Inspectors will closely review equipment logs, maintenance, and calibration schedules. Instruments used for analytical testing must be qualified (IQ/OQ/PQ), and calibration must be traceable to national or international standards.
Common items to prepare:
-
- Calibration certificates
-
- Data and maintenance logs
-
- Equipment cleaning procedures
-
- Usage logs and audit trails
3. Compliance to Internal Procedures Strengthen Data Integrity and Documentation Practices
Audit readiness is not just about passing the audit — it’s about consistent data integrity. Ensure all raw data is legible, attributable, and securely stored.
Tips:
-
- Use validated electronic systems with audit trails (e.g. LIMS, CDS)
-
- Clearly record calculations, chromatograms, and manual integrations
-
- Control access and avoid shared passwords
-
- Train analysts in ALCOA+ principles (Attributable, Legible, Contemporaneous, Original, Accurate)
4. Conduct a Mock Analytical Audit
A mock audit helps identify weaknesses before the real thing. Internal QA or an external consultant can simulate an audit to test documentation, staff responses, and system readiness.
Include:
-
- Document walkthroughs
-
- Data review spot-checks
-
- Sample interview questions for analysts
-
- Tracking corrective actions and establishing practical timeframes
Benefits of Working with an Audit-Ready CDMO
Pharmaceutical sponsors working with a Contract Development and Manufacturing Organisation (CDMO) must ensure their partner meets global audit expectations. At PharmSky, our analytical services are supported by:
-
- Validated methods and GMP-qualified equipment
-
- Transparent documentation and quality systems
-
- Strong track record of successful audits and inspections
-
- Continuous training and internal quality audits
Working with a partner who anticipates audit requirements helps reduce delays and build regulatory confidence — especially when scaling from preclinical studies to clinical trial manufacturing.
Conclusion
Preparing for an analytical audit requires more than compiling lab notebooks. It demands end-to-end control of equipment compliance, data integrity, and documentation standards.
Whether you’re managing your own lab or outsourcing to a CDMO, ensuring audit readiness can significantly impact the pace and success of your drug development program. For analytical support that meets global compliance standards, explore PharmSky’s full range of specialised analytical services or contact our team for audit-ready collaboration.
